[go: up one dir, main page]

NO900674D0 - Immunglobulin, fremgangsmaate til dets fremstilling av anvendelse avimmunglobulinet. - Google Patents

Immunglobulin, fremgangsmaate til dets fremstilling av anvendelse avimmunglobulinet.

Info

Publication number
NO900674D0
NO900674D0 NO1990900674A NO900674A NO900674D0 NO 900674 D0 NO900674 D0 NO 900674D0 NO 1990900674 A NO1990900674 A NO 1990900674A NO 900674 A NO900674 A NO 900674A NO 900674 D0 NO900674 D0 NO 900674D0
Authority
NO
Norway
Prior art keywords
avimmunglobulin
immunglobulin
procedure
manufacturing
Prior art date
Application number
NO1990900674A
Other languages
English (en)
Other versions
NO180271C (no
NO180271B (no
NO900674L (no
Inventor
Laurence M Cummins
Jean Pierre Allain
Lawrence A Falk Jr
Richard M Condie
Henry H Balfour Jr
Frank S Rhame
Original Assignee
Univ Minnesota
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Minnesota, Abbott Lab filed Critical Univ Minnesota
Publication of NO900674D0 publication Critical patent/NO900674D0/no
Publication of NO900674L publication Critical patent/NO900674L/no
Publication of NO180271B publication Critical patent/NO180271B/no
Publication of NO180271C publication Critical patent/NO180271C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO900674A 1987-08-11 1990-02-12 Immunoglobulin, fremgangsmåte til dets fremstilling og anvendelse av immunoglobulinet NO180271C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8442687A 1987-08-11 1987-08-11
PCT/US1988/002768 WO1989001339A1 (en) 1987-08-11 1988-08-10 Hyper-immune globulin against hiv

Publications (4)

Publication Number Publication Date
NO900674D0 true NO900674D0 (no) 1990-02-12
NO900674L NO900674L (no) 1990-02-12
NO180271B NO180271B (no) 1996-12-09
NO180271C NO180271C (no) 1997-03-19

Family

ID=22184901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900674A NO180271C (no) 1987-08-11 1990-02-12 Immunoglobulin, fremgangsmåte til dets fremstilling og anvendelse av immunoglobulinet

Country Status (11)

Country Link
EP (1) EP0379516B1 (no)
JP (1) JPH0796560B2 (no)
KR (1) KR970003056B1 (no)
AU (1) AU618555B2 (no)
DE (2) DE379516T1 (no)
DK (1) DK35290A (no)
FI (1) FI900670A0 (no)
IE (1) IE62584B1 (no)
NO (1) NO180271C (no)
NZ (1) NZ225796A (no)
WO (1) WO1989001339A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640511B1 (fr) * 1988-12-15 1993-04-23 Merieux Inst Medicaments pour le traitement ou la prevention par immunisation passive de l'infection par le virus hiv et procede de preparation
ATE266676T1 (de) 1996-03-12 2004-05-15 Ovogenix Immunpharma Gmbh Verwendung von aviären, vitellinen, gegen hiv- antigene gerichteten antikörpern zur herstellung pharmazeutischer zubereitungen
AU3596197A (en) * 1996-07-10 1998-02-02 Nabi Highly synergistic neutralization of hiv through combinations of monoclonal and polyclonal antibodies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE54757T1 (de) * 1985-02-05 1990-08-15 Us Commerce Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
WO1988007375A1 (en) * 1987-03-23 1988-10-06 Hiver Limited Novel vaccines

Also Published As

Publication number Publication date
EP0379516B1 (en) 1993-10-06
AU2322588A (en) 1989-03-09
DK35290D0 (da) 1990-02-09
JPH02504514A (ja) 1990-12-20
WO1989001339A1 (en) 1989-02-23
IE882455L (en) 1989-02-11
KR890701133A (ko) 1989-12-19
DE379516T1 (de) 1991-01-17
DE3884811D1 (de) 1993-11-11
JPH0796560B2 (ja) 1995-10-18
DK35290A (da) 1990-02-09
AU618555B2 (en) 1992-01-02
NZ225796A (en) 1991-08-27
DE3884811T2 (de) 1994-02-24
FI900670A0 (fi) 1990-02-09
NO180271C (no) 1997-03-19
EP0379516A1 (en) 1990-08-01
NO180271B (no) 1996-12-09
KR970003056B1 (ko) 1997-03-14
NO900674L (no) 1990-02-12
IE62584B1 (en) 1995-02-08

Similar Documents

Publication Publication Date Title
NO912848D0 (no) Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.
NO884063D0 (no) Fremgangsmaate til fremstilling av tungtantennbare polyuretanskumstoffer.
NO821586L (no) Fremgangsmaate til fremstilling av 1,2-diamino-cyklobuten-3,4-dioner.
NO883475D0 (no) Fremgangsmaate for fremstilling av antibakterielle kinoloner.
FI881152A (fi) Foerfarande foer framstaellning av tiazolderivat, med kolinergisk aktivitet.
FI883970A0 (fi) Anordning foer utbredning av haorkosmetiska produkter med flera komponenter, i synnerhet haorfaerger.
NO864448D0 (no) Fremgangsmaate til fremstilling av varmefaste, formede artikler.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NO882295D0 (no) Fremgangsmaate for fremstilling av paryledimeren.
NO880473D0 (no) Fremgangsmaate til fremstilling av substituerte 3,4-dihydro-2h-benzopyraner.
NO154879C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO904874D0 (no) Fremgangsmaate for fremstilling av dopet glass, og anvendelse av glasset.
NO153645C (no) Fremgangsmaate til fremstilling av asbestfrie, glassfiberarmerte sementprodukter.
NO154547C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO155575C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO885200L (no) Fremgangsmaate for fremstilling av pro-legemidler.
NO900674D0 (no) Immunglobulin, fremgangsmaate til dets fremstilling av anvendelse avimmunglobulinet.
NO882028L (no) Fremgangsmaate for fremstilling av cardiotone, tricykliskeimidazoloner.
NO801613L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO158621C (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO880409D0 (no) Fremgangsmaate for fremstilling av 14,15-substituerte lanosteroler.
NO156863B (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
NO885088L (no) Omslagsmateriale, fremgangsmaate for dets fremstilling og fremgangsmaate til bruk av materialet.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
FI873050A0 (fi) Foerfarande foer framstaellning av 6-amino-1,2-dihydro-1-hydroxi-2-imino-4-piperidinopyrimidin.